Editorial Type:
Article Category: Review Article
 | 
Online Publication Date: 19 Jan 2021

Clinical and Histological Outcomes of Maxillary Sinus Floor Augmentation With Synthetic Bone Substitutes for Dental Implant Treatment: A Meta-Analysis

DDS, MS,
DDS,
MD, DDS, MS, PhD, EBOS, OMFS,
DDS, MS, PhD, and
MD, DDS, MS, PhD
Page Range: 158 – 167
DOI: 10.1563/aaid-joi-D-20-00202
Save
Download PDF

The main objective of this study was to compare the clinical and histological results of synthetic bone substitutes used in maxillary sinus floor augmentation. A systematic review and meta-analysis was performed by searching the PubMed/MEDLINE, Scopus, and Cochrane databases for studies of the success of endosseous dental implant, implant failure, peri-implant marginal bone loss, newly formed bone, and residual bone graft material. After the search, 10 randomized clinical trials were included, with 4 studies ranging from low to unclear risk of bias were used for meta-analysis, comparing biphasic calcium phosphate (BCP) and deproteinized bovine bone (DBB). A greater amount of residual graft material (mean difference [MD]: −4.80 mm; 95% CI: −9.35 to −0.26; P = .040) was found in the DBB group. No other statistically significant differences were found between BCP and DBB for the remaining outcomes. Our results suggested that BCP can be considered a suitable alternative to DBB in maxillary sinus floor augmentation due to its clinical and histological results.

<bold>
  <sc>Figure 1</sc>
  .
</bold>
Figure 1 .

PRISMA flow diagram showing the study selection process.


<bold>
  <sc>Figure 2</sc>
  .
</bold>
Figure 2 .

Risk-of-bias assessment of selected studies following the Cochrane Handbook for Systematic Review of Interventions.


Contributor Notes

Corresponding author, e-mail: ocamps@ub.edu
  • Download PDF